>>Signaling Pathways>> Cardiovascular>> Hypertension>>Perindoprilat

Perindoprilat (Synonyms: S-9780)

Catalog No.GC44599

Perindoprilat(S 9780)은 1.5~3.2nM 범위의 IC50 값을 갖는 안지오텐신 전환 효소(ACE) 억제제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Perindoprilat Chemical Structure

Cas No.: 95153-31-4

Size 가격 재고 수량
1mg
US$74.00
재고 있음
5mg
US$176.00
재고 있음
10mg
US$278.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Perindoprilat is the active metabolite of perindopril, an inhibitor of angiotensin converting enzyme (ACE) that has efficacy against hypertension. [1] Perindoprilat specifically and competitively inhibits ACE in vitro with IC50 values ranging between 1.5 and 3.2 nM. Elimination of perindoprilat is decreased in the elderly and in patients with heart or renal failure.[1][2][3]

Reference:
[1]. Wang, J.g., Pimenta, E., and Chwallek, F. Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril. Vascular Health and Risk Management 10, 189-200 (2014).
[2]. Sennesael, J., Ali, A., Sweny, P., et al. The pharmacokinetics of perindopril and its effects of serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure. Br.J.Clin.Pharmac. 33, 93-99 (1992).
[3]. Parker, E., Aarons, L., Rowland, M., et al. The pharmacokinetics of perindoprilat in normal volunteers and patients: Influence of age and disease state. European Journal of Pharmaceutical Sciences 26(1), 104-113 (2005).

리뷰

Review for Perindoprilat

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Perindoprilat

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.